These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2361653)

  • 1. Tissue polypeptide antigen in thyroid tumours of follicular cell origin: an immunohistochemical re-evaluation for diagnostic purposes.
    Tuccari G; Barresi G
    Histopathology; 1990 Apr; 16(4):377-81. PubMed ID: 2361653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical demonstration of melanotransferrin (p97) in thyroid tumors of follicular cell origin.
    Barresi G; Tuccari G
    Pathology; 1994 Apr; 26(2):127-9. PubMed ID: 8090582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms.
    Nonaka D; Tang Y; Chiriboga L; Rivera M; Ghossein R
    Mod Pathol; 2008 Feb; 21(2):192-200. PubMed ID: 18084247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunohistochemical and serological demonstration of thyreoglobulin tissue polypeptide antigen, carcinoembryonic antigen and calcitonin in diversely differentiated thyroid gland carcinomas and thyroid gland adenomas].
    Vogel J; Oehr P; Grouls V
    Pathologe; 1985 May; 6(3):133-40. PubMed ID: 3892526
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression of keratin 19 distinguishes papillary thyroid carcinoma from follicular carcinomas and follicular thyroid adenoma.
    Schelfhout LJ; Van Muijen GN; Fleuren GJ
    Am J Clin Pathol; 1989 Nov; 92(5):654-8. PubMed ID: 2479256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of serum tissue polypeptide specific antigen in patients with thyroid carcinoma.
    Suzuki S; Furukawa H; Tsuchiya A
    Thyroid; 1999 Sep; 9(9):921-5. PubMed ID: 10524571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical diagnosis of papillary thyroid carcinoma.
    Cheung CC; Ezzat S; Freeman JL; Rosen IB; Asa SL
    Mod Pathol; 2001 Apr; 14(4):338-42. PubMed ID: 11301350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CA 50 and CA 19-9 antigen expression in normal, hyperplastic, and neoplastic thyroid tissue.
    Vierbuchen M; Schröder S; Uhlenbruck G; Ortmann M; Fischer R
    Lab Invest; 1989 May; 60(5):726-32. PubMed ID: 2716285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoblastoma expression in thyroid neoplasms.
    Anwar F; Emond MJ; Schmidt RA; Hwang HC; Bronner MP
    Mod Pathol; 2000 May; 13(5):562-9. PubMed ID: 10824929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of Leu-7 antigen (HNK-1) in thyroid tumors: its usefulness as a diagnostic marker for follicular and papillary carcinomas.
    Ghali VS; Jimenez EJ; Garcia RL
    Hum Pathol; 1992 Jan; 23(1):21-5. PubMed ID: 1371984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical demonstration of ceruloplasmin in follicular adenomas and thyroid carcinomas.
    Tuccari G; Barresi G
    Histopathology; 1987 Jul; 11(7):723-31. PubMed ID: 3623436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trefoil factor 3 immunohistochemical characterization of follicular thyroid lesions from tissue microarray.
    Patel MR; Bryson PC; Shores CG; Hart CF; Thorne LB; Deal AM; Zanation AM
    Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):590-6. PubMed ID: 19528408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CITED1 protein expression suggests Papillary Thyroid Carcinoma in high throughput tissue microarray-based study.
    Prasad ML; Pellegata NS; Kloos RT; Barbacioru C; Huang Y; de la Chapelle A
    Thyroid; 2004 Mar; 14(3):169-75. PubMed ID: 15072698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunohistochemical study of leu 7 and PCNA expression in thyroid neoplasms.
    Fucich LF; Freeman SM; Marrogi AJ
    Biotech Histochem; 1996 Nov; 71(6):298-303. PubMed ID: 8957557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen-receptor protein in thyroid neoplasms. An immunohistochemical analysis of papillary carcinoma, follicular carcinoma, and follicular adenoma.
    Diaz NM; Mazoujian G; Wick MR
    Arch Pathol Lab Med; 1991 Dec; 115(12):1203-7. PubMed ID: 1768209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of blood-group-related carbohydrate antigens in thyroid neoplasms].
    Yokota M; Yane K; Tanaka O; Miyahara H; Matsunaga T; Ito N
    Nihon Jibiinkoka Gakkai Kaiho; 1995 Sep; 98(9):1381-6. PubMed ID: 8523166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical study of type-1 blood antigen expressions in thyroid tumors: the significance for papillary carcinomas.
    Kamoshida S; Ogane N; Yasuda M; Muramatsu T; Bessho T; Kajiwara H; Osamura RY
    Mod Pathol; 2000 Jul; 13(7):736-41. PubMed ID: 10912932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermediate-filament expression in thyroid gland carcinomas.
    Schröder S; Dockhorn-Dworniczak B; Kastendieck H; Böcker W; Franke WW
    Virchows Arch A Pathol Anat Histopathol; 1986; 409(6):751-66. PubMed ID: 3094239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of CD56 immunohistochemistry in thyroid lesions.
    Pyo JS; Kim DH; Yang J
    Int J Biol Markers; 2018 May; 33(2):161-167. PubMed ID: 29799356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumours. Preferential reactivity with malignant tumours.
    Miettinen M; Kärkkäinen P
    Virchows Arch; 1996 Nov; 429(4-5):213-9. PubMed ID: 8972756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.